3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Glioblastoma
77
Prostatic Neoplasms
56
Carcinoma, Non-Small-Cell Lung
50
Breast Neoplasms
49
Esophageal Neoplasms
47
Rectal Neoplasms
41
Lung Neoplasms
40
Squamous Cell Carcinoma of Head and Neck
32
Gliosarcoma
31
Head and Neck Neoplasms
30
Brain Neoplasms
30
Pancreatic Neoplasms
29
Uterine Cervical Neoplasms
27
Neoplasm Metastasis
23
Glioma
23
Neoplasms
22
Oropharyngeal Neoplasms
20
Esophageal Squamous Cell Carcinoma
20
Sarcoma
19
Melanoma
18
Astrocytoma
17
Adenocarcinoma Of Esophagus
15
Stomach Neoplasms
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Carcinoma, Squamous Cell
12
Urinary Bladder Neoplasms
11
Lymphoma, Follicular
11
Central Nervous System Neoplasms
11
Carcinoma
11
Burkitt Lymphoma
10
Interventions
Pemetrexed
39
Cisplatin
33
pembrolizumab
21
Nivolumab
17
Carboplatin
16
Ipilimumab
13
Gemcitabine
10
Cyclophosphamide
9
fludarabine
6
durvalumab
6
Bevacizumab
6
Radiotherapy, Intensity-Modulated
4
LMB-100
4
Dexamethasone
4
tremelimumab
3
tazemetostat
3
spartalizumab
3
olaparib
3
niraparib
3
atezolizumab
3
anetumab ravtansine
3
amatuximab
3
Vinorelbine
3
Paclitaxel
3
Imatinib Mesylate
3
Cerebral Decortication
3
tislelizumab
2
sargramostim
2
fludarabine phosphate
2
defactinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mesothelioma
×
Radiation
×
Clear all
NCT01604005
2018-01-29
PIT
The Christie NHS Foundation Trust
Phase 3
Terminated
375 enrolled